Alector to Participate in Upcoming Healthcare Conferences
Alector (Nasdaq: ALEC), a clinical-stage biotechnology company focused on immuno-neurology, has announced its participation in three upcoming healthcare conferences in September 2024. The company will be present at:
- Morgan Stanley 22nd Annual Global Healthcare Conference on September 5
- H.C. Wainwright 26th Annual Global Investment Conference on September 9
- 2024 Cantor Global Healthcare Conference on September 17
All events will take place in New York City, featuring fireside chats with Alector's management. Webcasts of these presentations will be available on Alector's investor relations website, with replays accessible for 90 days after each event.
Alector (Nasdaq: ALEC), un'azienda biotecnologica in fase clinica focalizzata sull'immuno-neurologia, ha annunciato la sua partecipazione a tre conferenze sanitarie in programma a settembre 2024. L'azienda sarà presente a:
- La 22ª Conferenza Annuale Globale sulla Salute di Morgan Stanley il 5 settembre
- La 26ª Conferenza Annuale Globale sugli Investimenti di H.C. Wainwright il 9 settembre
- La Conferenza Globale sulla Salute di Cantor 2024 il 17 settembre
Tutti gli eventi si svolgeranno a New York City, con interviste dal vivo con la direzione di Alector. Webcast di queste presentazioni saranno disponibili sul sito web delle relazioni con gli investitori di Alector, con le riproduzioni accessibili per 90 giorni dopo ciascun evento.
Alector (Nasdaq: ALEC), una empresa biotecnológica en etapa clínica centrada en la inmunoneurología, ha anunciado su participación en tres próximas conferencias de salud en septiembre de 2024. La empresa estará presente en:
- La 22ª Conferencia Anual Global de Salud de Morgan Stanley el 5 de septiembre
- La 26ª Conferencia Anual Global de Inversión de H.C. Wainwright el 9 de septiembre
- La Conferencia Global de Salud de Cantor 2024 el 17 de septiembre
Todos los eventos tendrán lugar en la ciudad de Nueva York, con charlas informales con la dirección de Alector. Webcasts de estas presentaciones estarán disponibles en el sitio web de relaciones con inversionistas de Alector, con reproducciones accesibles durante 90 días después de cada evento.
알렉터 (Nasdaq: ALEC)는 면역신경학에 중점을 둔 임상 단계의 생명공학 회사로, 2024년 9월에 예정된 세 가지 의료 회의에 참가한다고 발표했습니다. 회사는 다음 회의에 참석할 예정입니다:
- 모건 스탠리 제22회 연례 글로벌 의료 회의 - 9월 5일
- H.C. 웨인라이트 제26회 연례 글로벌 투자 회의 - 9월 9일
- 2024 캔터 글로벌 의료 회의 - 9월 17일
모든 행사는 뉴욕 시에서 진행되며, 알렉터 경영진과의 화상 대담이 진행됩니다. 웹캐스트는 알렉터의 투자자 관계 웹사이트에서 볼 수 있으며, 각 이벤트 후 90일 동안 다시 시청할 수 있습니다.
Alector (Nasdaq: ALEC), une entreprise de biotechnologie en phase clinique axée sur l'immuno-neurologie, a annoncé sa participation à trois conférences santé à venir en septembre 2024. L'entreprise sera présente à :
- La 22e Conférence Annuelle Mondiale de la Santé de Morgan Stanley le 5 septembre
- La 26e Conférence Annuelle Mondiale de l'Investissement de H.C. Wainwright le 9 septembre
- La Conférence Mondiale de la Santé de Cantor 2024 le 17 septembre
Tous les événements auront lieu à New York, avec des discussions informelles avec la direction d'Alector. Les webcasts de ces présentations seront disponibles sur le site web des relations avec les investisseurs d'Alector, avec des rediffusions accessibles pendant 90 jours après chaque événement.
Alector (Nasdaq: ALEC), ein biotechnologisches Unternehmen in der klinischen Phase, das sich auf Immunneurologie spezialisiert hat, hat seine Teilnahme an drei bevorstehenden Gesundheitskonferenzen im September 2024 angekündigt. Das Unternehmen wird an folgenden Veranstaltungen teilnehmen:
- 22. Jahrestagung zur globalen Gesundheitswirtschaft von Morgan Stanley am 5. September
- 26. Jahrestagung zur globalen Investitionskonferenz von H.C. Wainwright am 9. September
- 2024 Cantor Global Healthcare Conference am 17. September
Alle Veranstaltungen finden in New York City statt und beinhalten Gespräche am Kamin mit dem Management von Alector. Webcasts dieser Präsentationen sind auf der Website für Anlegerbeziehungen von Alector verfügbar, wobei Wiederholungen 90 Tage nach jeder Veranstaltung zugänglich sind.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in the following upcoming investor conferences:
- Morgan Stanley 22nd Annual Global Healthcare Conference (New York, New York)
- Thursday, September 5, 2024, at 7:45 a.m. ET, fireside chat
- H.C. Wainwright 26th Annual Global Investment Conference (New York, New York)
- Monday, September 9, 2024, at 10:00 a.m. ET, fireside chat
- 2024 Cantor Global Healthcare Conference (New York, New York)
- Tuesday, September 17, 2024, at 9:45 a.m. ET, fireside chat
A webcast of each presentation will be available on the “Events & Presentations” page within the Investors section of the Alector website at http://investors.alector.com. Replays of the webcasts will be available on the Alector website for 90 days following the presentation dates.
About Alector
Alector is a clinical-stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. Alector has discovered and is developing a broad portfolio of innate immune system programs, designed to functionally repair genetic mutations that cause dysfunction of the brain’s immune system and enable rejuvenated immune cells to counteract emerging brain pathologies. Alector’s immuno-neurology product candidates are supported by biomarkers and seek to treat indications, including Alzheimer’s disease and genetically defined frontotemporal dementia patient populations. Alector is headquartered in South San Francisco, California. For additional information, please visit www.alector.com.
Alector Contacts:
Alector
Katie Hogan
202-549-0557
katie.hogan@alector.com
1AB (media)
Dan Budwick
973-271-6085
dan@1abmedia.com
Argot Partners (investors)
Laura Perry
212.600.1902
alector@argotpartners.com
FAQ
What investor conferences will Alector (ALEC) participate in during September 2024?
Where can investors access the webcasts of Alector's (ALEC) conference presentations?
How long will the replays of Alector's (ALEC) conference presentations be available?
What type of company is Alector (ALEC)?
